Inside Innovation

Seattle-based biotech, A-Alpha Bio, is a new resident of an 11,000-square-foot office space in Belltown tower after the move from the University of Washington’s Fluke

William Canestaro, managing director of Washington Research Foundation and WRF Capital, has helped oversee the portfolios of 40 startups. He recently shared his expertise and

Following positive results in phase II of a multi-part, midstage trial for advanced and early-stage classical Hodgkin lymphoma (cHL), Seagen continues to plan to expand

Bothell-based company Athira Pharma recently presented biomarker data from the Phase I ACT-AD study at the 15th Clinical Trials on Alzheimer’s Disease conference. According to

CBRE recently announced the addition of three new life sciences real estate specialists to its Seattle office: Chris Moe, Hans Kemp, and Austin Arper. Moe

A new 11-story life sciences building is underway in Seattle’s Denny Triangle neighborhood. The 1916 Boren tower will include 282,700 square feet of space, of

The life science industry tends to be a buffer when the economy slows; in fact, a recent analysis by the Puget Sound Business Journal indicates

The Biotechnology Innovation Organization (BIO) has released the tenth annual biennial report showcasing employment and economic data of the nation’s biosciences industry. The report highlights

Cajal Neuroscience, a Seattle-based startup, announced a $96 million funding round and released details on its strategy for developing treatments for neurodivergent diseases. The company

Seattle-based biotech HDT Corp. announced a $49 million funding round as part of a government project in partnership with the University of Texas Medical Branch

One Item, a Seattle-area startup, is continuing its partnership with the University of Arkansas for Medical Studies (UAMS), expanding a study of rural Arkansas communities

Cuervo, a Seattle-based vaccine startup, raised $26 million in a funding round with participation from RA Capital Management, Adjuvant Capital, and founding investor GC Biopharma,